(Q37688083)

22 August 2017

1 reference

title

Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder (English)

1 reference

obsessive-compulsive disorder

22 August 2017

0 references

1 reference

0 references

author name string

Min-Seong Koo

1

1 reference

22 August 2017

Eun-Ju Kim

2

1 reference

22 August 2017

Daeyoung Roh

3

1 reference

22 August 2017

Chan-Hyung Kim

4

1 reference

22 August 2017

publication date

1 February 2010

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

22 August 2017

published in

1 reference

22 August 2017

volume

10

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

275-290

1 reference

Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Clinical practice. Obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

8-week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Early- versus late-onset obsessive-compulsive disorder: investigating genetic and clinical correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Dopamine Transporter Density in the Basal Ganglia in Obsessive-Compulsive Disorder, Measured with [123I]IPT SPECT before and after Treatment with Serotonin Reuptake Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Enhanced Dopamine Transporter Density in Psychotropic-Naive Patients With Obsessive-Compulsive Disorder Shown by [ 123 I]β-CIT SPECT

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Behavioral aspects of serotonin-dopamine interaction in the monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Chlorpromazine in obsessive-compulsive and allied disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Massive doses of trifluoperazine in the treatment of compulsive rituals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Obsessive–compulsive symptoms induced by atypical antipsychotics. A review of the reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Risperidone-induced obsessive-compulsive symptoms: a series of six cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Obsessive-compulsive symptoms with olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Unmet need for services and interventions among adolescents with mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

A review of antipsychotics in the treatment of obsessive compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Contemporary assessment and pharmacotherapy of Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Effects of quinpirole on central dopamine systems in sensitized and non-sensitized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Obsessive-compulsive disorder: a disorder of pessimal (non-functional) motor behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Left anterior subregion of orbitofrontal cortex volume reduction and impaired organizational strategies in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Orbital Frontal and Amygdala Volume Reductions in Obsessive-compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomograp

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Obsessive-compulsive disorder and serotonin: is there a connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Effects of fenfluramine on plasma HVA in OCD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Autonomic activity in relation to cerebrospinal fluid neurochemistry in obsessive and disruptive children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Zolmitriptan (a 5-HT1B/1D receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Saccadic distractibility in cocaine dependent patients: a preliminary laboratory exploration of the cocaine-OCD hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Obsessive-compulsive symptoms following stimulants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

The relationship between cocaine-induced paranoia and compulsive foraging: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Methylphenidate-induced obsessive-compulsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Effects of catecholamine depletion with AMPT (alpha-methyl-para-tyrosine) in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

L-dopa and oculogyric crises.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Obsessive-compulsive disorder in youth with and without a chronic tic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Disruptive behavior in children with Tourette's syndrome: association with ADHD comorbidity, tic severity, and functional impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Case study: acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

A review of the treatment for refractory obsessive-compulsive disorder: from medicine to deep brain stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Dopamine D1 receptor binding in the striatum of patients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Transmission disequilibrium studies in early onset of obsessive-compulsive disorder for polymorphisms in genes of the dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

Association between the COMT locus and obsessive-compulsive disorder in females but not males

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.148

21 January 2018

Identifiers

DOI

10.1586/ERN.09.148

1 reference

22 August 2017

1 reference